European Archives - Page 575 of 1122 - European Medical Journal

EMJ Podcast: Antimicrobial Resistance: the next global crisis – what is the role of Urology?

In this podcast, we explore the burden and challenges of managing and treating uncomplicated urinary tract infections (uUTI) in the community setting in the community setting.

Talking to Alexey Cherchago

Alexey Cherchago, Head of Sales Excellence Europe, Sandoz, talks about leadership and the evolving medical sales representative role.

Webinar: Striving for better clinical outcomes in uncontrolled seizures

Join us for a thought-provoking online webinar, in the strive for better clinical outcomes in uncontrolled seizures.

New Research May Be Key to Tackling COVID-19

Researchers from the molecular biology department at The Pennsylvania State University, USA, have come up with an innovative strategy of using a non-functioning synthetic version of SARS-CoV-2 to annihilate the disease-causing alternative. This synthetic version of the COVID-19 virus has been proven to interfere with the growth process of the SARS-CoV-2 virus and could be developed as anti-viral therapy for the disease.

New Study on Blood-Based Biomarkers That Could Predict HIV Remission

The biomarkers found during the interruption of ART could help predict HIV remission by providing interpretative clues on the biological mechanisms of HIV duplication after stopping ART, as well as assist in the design of a new way to cure the disease.

Omega Valve Approach Developed to Combat Reflux

This procedure involves endoscopic creation of an antireflux ‘Omega’ valve, showing promise by acting as a durable barrier to reflux and exhibiting fewer symptoms than that seen in traditional fundoplication.

COVID-19 Vaccines Safe for Patients with Inflammatory Bowel Diseases

A study upon Pfizer and Moderna vaccines has revealed fewer complications in patients with inflammatory bowel diseases (IBD) compared with the general population.

EMJ Podcast: The Theory Behind Therapy

This week, Jonathan sits down with Professor John Markowitz, Professor of Clinical Psychiatry, and Research Psychiatrist at New York State Psychiatric Institute.

Ruxolitinib Cream Effective for Patients with Atopic Dermatitis

A study by Kim Papp looked at ruxolitinib as a topical cream for AD. Ruxolitinib works by inhibiting JAK1 and JAK2 on the cell surface and consequently affects the signalling cascade that would eventually produce pro-inflammatory cytokines.

Painful Psoriasis Flares Reduced by Switching to Balanced Diet

PSORIASIS is a painful inflammatory skin disease that affects approximately 125 million individuals worldwide. Currently, there is no cure for psoriasis.